Your browser doesn't support javascript.
loading
Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
Valdés-Mora, Fátima; Gould, Cathryn M; Colino-Sanguino, Yolanda; Qu, Wenjia; Song, Jenny Z; Taylor, Kylie M; Buske, Fabian A; Statham, Aaron L; Nair, Shalima S; Armstrong, Nicola J; Kench, James G; Lee, Kenneth M L; Horvath, Lisa G; Qiu, Minru; Ilinykh, Alexei; Yeo-Teh, Nicole S; Gallego-Ortega, David; Stirzaker, Clare; Clark, Susan J.
Afiliação
  • Valdés-Mora F; Histone Variants Group, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. f.valdesmora@garvan.org.au.
  • Gould CM; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. f.valdesmora@garvan.org.au.
  • Colino-Sanguino Y; St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW, 2010, Australia. f.valdesmora@garvan.org.au.
  • Qu W; Histone Variants Group, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Song JZ; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Taylor KM; Histone Variants Group, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Buske FA; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Statham AL; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Nair SS; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Armstrong NJ; Histone Variants Group, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Kench JG; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Lee KML; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Horvath LG; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Qiu M; Epigenetics Research Laboratory, Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
  • Ilinykh A; St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW, 2010, Australia.
  • Yeo-Teh NS; Mathematics and Statistics, Murdoch University, Perth, WA, 6150, Australia.
  • Gallego-Ortega D; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia.
  • Stirzaker C; Sydney Medical School, University of Sydney, Sydney, NSW, 2050, Australia.
  • Clark SJ; Clinical Prostate Cancer Research Group, Cancer Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
Nat Commun ; 8(1): 1346, 2017 11 07.
Article em En | MEDLINE | ID: mdl-29116202

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Histonas / Elementos Facilitadores Genéticos Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Histonas / Elementos Facilitadores Genéticos Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido